-DOCSTART- -X- O
Cyclophilin -X- _ O
( -X- _ O
Cyp -X- _ O
) -X- _ O
, -X- _ O
a -X- _ O
peptidyl-prolyl -X- _ O
cis-trans -X- _ O
isomerase -X- _ O
( -X- _ O
PPIase -X- _ O
) -X- _ O
, -X- _ O
acts -X- _ O
as -X- _ O
a -X- _ O
virulence -X- _ O
factor -X- _ O
in -X- _ O
many -X- _ O
bacteria -X- _ O
including -X- _ O
Staphylococcus -X- _ O
aureus. -X- _ O
The -X- _ O
enzymatic -X- _ O
activity -X- _ O
of -X- _ O
Cyp -X- _ O
is -X- _ O
inhibited -X- _ O
by -X- _ O
cyclosporin -X- _ B-Intervention
A -X- _ I-Intervention
( -X- _ I-Intervention
CsA -X- _ I-Intervention
) -X- _ I-Intervention
, -X- _ O
an -X- _ O
immunosuppressive -X- _ B-Intervention
drug. -X- _ I-Intervention
To -X- _ O
precisely -X- _ O
determine -X- _ O
the -X- _ O
unfolding -X- _ O
mechanism -X- _ O
and -X- _ O
the -X- _ O
domain -X- _ O
structure -X- _ O
of -X- _ O
Cyp -X- _ O
, -X- _ O
we -X- _ O
have -X- _ O
investigated -X- _ O
a -X- _ O
chimeric -X- _ B-Patient
S. -X- _ I-Patient
aureus -X- _ I-Patient
Cyp -X- _ I-Patient
( -X- _ I-Patient
rCyp -X- _ I-Patient
) -X- _ I-Patient
using -X- _ O
various -X- _ O
probes. -X- _ O
Our -X- _ O
limited -X- _ O
proteolysis -X- _ O
and -X- _ O
the -X- _ O
consequent -X- _ O
analysis -X- _ O
of -X- _ O
the -X- _ O
proteolytic -X- _ O
fragments -X- _ O
indicate -X- _ O
that -X- _ O
rCyp -X- _ B-Outcome
is -X- _ I-Outcome
composed -X- _ I-Outcome
of -X- _ I-Outcome
one -X- _ I-Outcome
domain -X- _ I-Outcome
with -X- _ I-Outcome
a -X- _ I-Outcome
short -X- _ I-Outcome
flexible -X- _ I-Outcome
tail -X- _ I-Outcome
at -X- _ I-Outcome
the -X- _ I-Outcome
C-terminal -X- _ I-Outcome
end. -X- _ I-Outcome
We -X- _ I-Outcome
also -X- _ I-Outcome
show -X- _ I-Outcome
that -X- _ I-Outcome
the -X- _ I-Outcome
urea-induced -X- _ I-Outcome
unfolding -X- _ I-Outcome
of -X- _ I-Outcome
both -X- _ I-Outcome
rCyp -X- _ I-Outcome
and -X- _ I-Outcome
rCyp-CsA -X- _ I-Outcome
is -X- _ I-Outcome
completely -X- _ I-Outcome
reversible -X- _ I-Outcome
and -X- _ I-Outcome
proceeds -X- _ I-Outcome
via -X- _ I-Outcome
the -X- _ I-Outcome
synthesis -X- _ I-Outcome
of -X- _ I-Outcome
at -X- _ I-Outcome
least -X- _ I-Outcome
one -X- _ I-Outcome
stable -X- _ I-Outcome
intermediate. -X- _ I-Outcome
Both -X- _ O
the -X- _ O
secondary -X- _ O
structure -X- _ O
and -X- _ O
the -X- _ O
tertiary -X- _ O
structure -X- _ O
of -X- _ O
each -X- _ O
intermediate -X- _ O
appears -X- _ O
very -X- _ O
similar -X- _ O
to -X- _ O
those -X- _ O
of -X- _ O
the -X- _ O
corresponding -X- _ O
native -X- _ O
protein. -X- _ O
Conversely -X- _ O
, -X- _ O
the -X- _ O
hydrophobic -X- _ O
surface -X- _ O
areas -X- _ O
of -X- _ O
the -X- _ O
intermediates -X- _ O
are -X- _ O
comparatively -X- _ O
less. -X- _ O
Further -X- _ O
analyses -X- _ O
reveal -X- _ O
no -X- _ B-Outcome
loss -X- _ I-Outcome
of -X- _ I-Outcome
CsA -X- _ I-Outcome
binding -X- _ I-Outcome
activity -X- _ I-Outcome
in -X- _ I-Outcome
rCyp -X- _ I-Outcome
intermediate. -X- _ I-Outcome
The -X- _ O
thermodynamic -X- _ B-Outcome
stability -X- _ I-Outcome
of -X- _ I-Outcome
rCyp -X- _ I-Outcome
was -X- _ I-Outcome
also -X- _ I-Outcome
significantly -X- _ I-Outcome
increased -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
presence -X- _ I-Outcome
of -X- _ I-Outcome
CsA -X- _ I-Outcome
, -X- _ O
recommending -X- _ O
that -X- _ O
this -X- _ O
protein -X- _ O
could -X- _ O
be -X- _ O
employed -X- _ O
to -X- _ O
screen -X- _ O
new -X- _ O
CsA -X- _ O
derivatives -X- _ O
in -X- _ O
the -X- _ O
future -X- _ O
. -X- _ O

